Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. J of Skin. 2022;6(2):109-121. doi:10.25251/skin.6.2.4